Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.

The UK's National Screening Committee has recommended that only a very small group of men at high risk of prostate cancer ...

Acupath Laboratories announced today the integration of the ArteraAI Prostate Test into its diagnostic workflows, allowing for fast and convenient delivery of treatment insights. The ArteraAI Prostate ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announces the launch of the Prolaris + AI Test at the end of this month. Prolaris will be the ...

Routine prostate cancer screening has been rejected by the UK's independent screening committee despite significant pressure ...

Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of controversy.

Researchers have identified 17 unique genetic markers that are overexpressed by high-grade prostate cancers, which can be screened for accurately using a urine test. Experts say the test can help ...

The majority of men in the UK will not be offered prostate cancer screening following a final recommendation from a committee ...

NHS advisors have again rejected pleas for potentially life-saving routine prostate cancer screening after concluding that ...

Prostate cancer is known as the “invisible killer”. And if today’s recommendations from the UK National Screening Committee ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...

Former President Joe Biden received his last known blood test to check for prostate cancer in 2014, a spokesperson said Tuesday — two days after Biden revealed he has an aggressive form of prostate ...